Praxis Precision Medicines Inc (PRAX) Stock Price & News

PRAX:NASDAQ

Praxis Precision Medicines Inc

$345.30

-2.04%

(-7.18) 1D

$344.75

-0.16% (-0.55)

After hours

Closed: Sep 9, 4:00:00 PM GMT-4 · USD

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for PRAX...

Open

$352.80

High

$360.61

Low

$344.03

Mkt. cap

9.64B

Avg. vol.

395.35K

Volume

0.00

52-wk high

$392.70

52-wk low

$37.24

EPS

-$12.93

Beta

2.76

Shares outstanding

27.92M

No. of employees

168

Open

$352.80

High

$360.61

Low

$344.03

Mkt. cap

9.64B

Avg. vol.

395.35K

Volume

0.00

52-wk high

$392.70

52-wk low

$37.24

EPS

-$12.93

Beta

2.76

Shares outstanding

27.92M

No. of employees

168

Related stocks

RVMD

Revolution Medicines Inc

News stories

From web sources and news partners

https://www.dars.gov.et/

1 day ago

Praxis Precision Medicines (PRAX) Q2 2026 Earnings: Narrower Loss Beats Estimates by 23.14% - One-Time Gain Impact

About Praxis Precision Medicines Inc

CEO-

Employees168

Founded2015

HeadquartersBoston, Massachusetts, United States

SectorBiotechnology

Websitepraxismedicines.com

Analyst	Recommendation	Action	Price target	Projected	Date
Kevin Strang Goldman Sachs	Buy	Reiterated	$575.00	+66.5%	08/21/2026
Jay Olson Oppenheimer	Buy	Reiterated	$650.00	+88.2%	08/17/2026
Tiago Fauth Raymond James	Buy	Maintained	$945.00	+173.7%	08/17/2026
Douglas Tsao H.C. Wainwright	Buy	Reiterated	$1,201.00	+247.8%	08/10/2026
Yasmeen Rahimi Piper Sandler	Buy	Maintained	$1,200.00	+247.5%	08/07/2026
Justin Walsh JonesTrading	Buy	Reiterated	$441.00	+27.7%	08/07/2026
Danielle Brill Truist Financial	Buy	Maintained	$616.00	+78.4%	08/07/2026
Yatin Suneja Guggenheim	Buy	Reiterated	$800.00	+131.7%	08/06/2026
Brian Skorney Robert W. Baird	Buy	Maintained	$514.00	+48.9%	08/07/2026
Leonid Timashev RBC Capital	Buy	Reiterated	$462.00	+33.8%	08/06/2026
Benjamin Burnett Wells Fargo	Hold	Maintained	$362.00	+4.8%	08/07/2026
Ritu Baral TD Cowen	Buy	Maintained	$510.00	+47.7%	08/06/2026
Francois Brisebois LifeSci Capital	Buy	Reiterated	$754.00	+118.4%	08/08/2026
Ami Fadia Needham	Buy	Maintained	$582.00	+68.5%	08/06/2026
Andrew Tsai Jefferies	Buy	Maintained	$550.00	+59.3%	06/30/2026
Kambiz Yazdi BTIG	Buy	Maintained	$810.00	+134.6%	06/29/2026
Laura Chico Wedbush	Sell	Maintained	$162.00	-53.1%	06/02/2026
David Hoang Deutsche Bank	Buy	Maintained	$374.00	+8.3%	06/02/2026
Joon Lee Truist Financial	Buy	Initiated	$715.00	+107.1%	05/13/2026
Unknown Analyst Raymond James	Buy	Initiated	$815.00	+136%	04/08/2026
Rudy Li Wolfe Research	Buy	Maintained	$500.00	+44.8%	04/06/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	65.80M	77.51M	77.99M	69.42M
Cost of revenue	65.80M	77.51M	77.99M	69.42M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	12.56M	19.54M	27.87M	27.49M
Operating expense	12.56M	19.54M	27.87M	27.49M
Total operating expenses	78.36M	97.04M	105.86M	96.90M
Operating income	-78.36M	-97.04M	-105.86M	-96.90M
Other non operating income	-	-	-	-
EBT including unusual items	-73.93M	-88.91M	-92.56M	-83.72M
EBT excluding unusual items	-73.93M	-92.50M	-93.22M	-83.72M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-73.93M	-88.91M	-92.56M	-83.72M
Net profit margin	-	-	-	-
Earnings per share	-3.36	-3.50	-3.20	-2.87
Interest and investment income	4.42M	4.54M	12.64M	13.18M
Interest expense	-	-	-	-
Net interest expenses	4.42M	4.54M	12.64M	13.18M
Depreciation and amortization charges	-	-	-	-
EBITDA	-78.34M	-97.02M	-105.82M	-96.87M
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything